首页> 外文期刊>Progress in Artificial Intelligence >Acquisition of multidrug-resistant Enterobacterales during international travel: a systematic review of clinical and microbiological characteristics and meta-analyses of risk factors
【24h】

Acquisition of multidrug-resistant Enterobacterales during international travel: a systematic review of clinical and microbiological characteristics and meta-analyses of risk factors

机译:在国际旅行期间采集多药抗生素:对临床和微生物学特征的系统审查和危险因素的荟萃分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background International tourism increased from 25 million tourist arrivals in 1950 to over 1.3 billion in 2017. These travelers can be exposed to (multi) resistant microorganisms, may become colonized, and bring them back home. This systematic review aims to identify the carriage rates of multidrug-resistant Enterobacterales (MDR-E) among returning travelers, to identify microbiological methods used, and to identify the leading risk factors for acquiring MDR-E during international travel. Methods Articles related to our research question were identified through a literature search in multiple databases (until June 18, 2019) - Embase, Medline Ovid, Cochrane, Scopus, Cinahl, Web of Science, and Google Scholar. Results Out of 3211 potentially relevant articles, we included 22 studies in the systematic review, and 12 studies in 7 random-effects meta-analyses. Highest carriage rates of MDR-E were observed after travel to Southern Asia (median 71%), followed by travel to Northern Africa (median 42%). Carbapenemase-producing Enterobacterales (CPE) were identified in 5 out of 22 studies, from a few patients. However, in only eight out of 22 studies (36.4%) the initial laboratory method targeted detection of the presence of CPE in the original samples. The risk factor with the highest pooled odds ratio (OR) for MDR-E was travel to Southern Asia (pooled OR = 14.16, 95% confidence interval [CI] = 5.50 to 36.45), followed by antibiotic use during travel (pooled OR = 2.78, 95% CI = 1.76 to 4.39). Conclusions Risk of acquiring MDR-E while travelling increases depending on travel destination and if antibiotics are used during travel. This information is useful for the development of guidelines for healthcare facilities with low MDR-E prevalence rates to prevent admission of carriers without appropriate measures. The impact of such guidelines should be assessed.
机译:背景技术国际旅游从1950年的2500万到2017年增加到超过13亿美元。这些旅行者可以接触(多种)抗性微生物,可能会殖民,并将他们带回家里。该系统审查旨在识别返回旅行者中多药抗生素(MDR-E)的携带型耐肠杆菌(MDR-E)的托架率,以鉴定使用的微生物方法,并确定在国际旅行期间收购MDR-E的主要风险因素。方法通过多个数据库中的文献搜索来确定与我们的研究问题相关的文章(直到2019年6月18日) - Embase,Medline Ovid,Cochrane,Scopus,Cinahl,Science和Google Scholar。结果在3211个潜在的相关文章中,我们在系统审查中包括22项研究,并在7种随机效应中分析中进行了12项研究。在向亚洲南亚(中位数71%)之后观察MDR-E的最高支架率,然后前往北非(中位数42%)。产生的碳碱酶活性的肠杆菌(CPE)在22项研究中,来自少数患者中的5项鉴定。然而,在22项研究中只有八个(36.4%)初始实验室方法靶向检测原始样品中CPE的存在。具有最高汇集的赔率比(或)对于MDR-E的危险因素是前往南亚(汇集或= 14.16,95%置信区间[CI] = 5.50至36.45),然后在旅行期间使用抗生素(汇集或= 2.78,95%CI = 1.76至4.39)。结论获取MDR-e的风险在旅行时增加,根据旅行目的地,如果在旅行期间使用抗生素。这些信息对于制定具有低MDR-E流行率的医疗保健设施指南,以防止承认承运人而无需适当措施。应评估这些准则的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号